Topical application of jak1/jak2 inhibitor momelotinib exhibits significant anti-inflammatory responses in dncb-induced atopic dermatitis model mice

HIGHLIGHTS

• who: Wenyu Jin and colleagues from the Division of Dermatology, Department of Clinical Medicine, Medical College of Yanbian University have published the article: Topical Application of JAK1/JAK2 Inhibitor Momelotinib Exhibits Significant Anti-Inflammatory Responses in DNCB-Induced Atopic Dermatitis Model Mice, in the Journal: (JOURNAL)
• what: The authors evaluated the efficacy of MMB as a novel JAK1/JAK2 inhibitor in DNCB-induced AD mice and TSLP-activated dendritic cells. After and B cell dysfunction may high be the main cause of IgE level elevation in STAT3-mutated mice . cross-linking with antigens, level of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.